Insights On Drug Development

  1. Streamlining Drug Development Through Bioassays And Functional Assessments 5/19/2025

    Discover how strategically selecting and applying the right functional assessments can unlock the full potential of your therapeutic candidates and accelerate their path to success.

  2. The Next-Gen Cell Line Development Platform Fueling Biologics Success 5/19/2025

    Whether you're navigating the challenges of complex biologics or seeking a faster path to the clinic, this discussion sheds light on how innovation in CLD can be a game-changer for your pipeline.

  3. Robust, Scalable Strategy For Monodisperse Nanosuspensions Of Poorly Soluble Drugs 5/16/2025

    By tailoring the formulation strategy, selecting the appropriate excipients, and fine-tuning process conditions, see how our team was able to improve bioavailability and in vivo exposure.

  4. Modelling TPDs Utilizing Computational And Medicinal Chemistry Approaches 5/16/2025

    Through a carefully executed strategy, see how we identified novel degrader molecules with the right physicochemical properties to achieve robust degradation of the target Protein of Interest (POI).

  5. Nanomedicine Modalities Find Path To Clinic Through Analytics 5/16/2025

    Lipid nanoparticles have revolutionized drug delivery, ushering in a new era of nanomedicine. Discover how advanced analytical tools are accelerating next-generation LNP therapeutics.

  6. Adapting A rcAAV Assay For Commercial Manufacturing 5/15/2025

    Witness how to implement sensitive, cell-based qPCR assays to reliably detect rcAAVs and safeguard the integrity of your rAAV gene therapy manufacturing process.

  7. Engineering The Future Of Lipsomal Drug Delivery 5/14/2025

    Explore our full collection of case studies to discover how liposome technology is transforming drug delivery across a wide range of therapies.

  8. Complexing RNPs: Have You Established Your Clinical Acceptance Criteria? 5/13/2025

    When using CRISPR-Cas proteins for gene editing, it’s critical to ensure consistency and quality at each stage of the manufacturing process. The FDA recommends establishing well-defined acceptance criteria for the RNP formation step.

  9. Pharmacokinetic Study Of Salbutamol Through Nose Only Exposure In CD-1 Male Mice 5/13/2025

    Explore how using advanced tools like the inExpose system can provide precise measurements of lung and plasma drug concentrations to optimize inhalation therapy for pulmonary treatments.

  10. Mass Spectrometry For Drug-Protein Interaction 5/13/2025

    Discover how mass spectrometry can transform your drug discovery efforts by delivering precise, reliable quantification of drug-protein interactions for optimized assay development and dosing strategies.